IL1B and Alzheimer disease: A recent systematic review summarized that UDCA reduces the levels of ROS, tumor necrosis factor alpha (TNFα), and interleukin-1 beta (IL-1β), exerting anti-apoptotic, oxidative stress and inflammatory effects in AD [106].